|1.||Wei, Qingyi: 4 articles (11/2011 - 02/2005)|
|2.||Hauser, Alan R: 3 articles (06/2015 - 12/2004)|
|3.||Merrill, A Rod: 3 articles (11/2012 - 04/2008)|
|4.||Liu, Zhensheng: 3 articles (11/2011 - 09/2006)|
|5.||Wang, Li-E: 3 articles (11/2011 - 09/2006)|
|6.||Hu, Jennifer J: 3 articles (09/2011 - 09/2004)|
|7.||Haag, Friedrich: 3 articles (08/2011 - 04/2006)|
|8.||Tan, Wen: 3 articles (08/2006 - 02/2005)|
|9.||Rangel, Stephanie M: 2 articles (06/2015 - 01/2014)|
|10.||Tang, Yi: 2 articles (01/2015 - 07/2013)|
03/01/2011 - " Although ADPRT is an important gene for cellular responses and tumor regulations, our study provides evidence that ADPRT variations do not affect HBV clearance and HCC occurrence."
12/01/2012 - "Racial and tissue-specific cancer risk associated with PARP1 (ADPRT) Val762Ala polymorphism: a meta-analysis."
09/15/2011 - "This cell death requires the mono-ADP-ribosyltransferase but not the deacetylase activity of SIRT6 and is mediated by the activation of both the p53 and p73 apoptotic signaling cascades in cancer cells by SIRT6. "
01/01/2009 - "Polymorphisms of DNA repair genes: ADPRT, XRCC1, and XPD and cancer risk in genetic epidemiology."
02/01/2008 - "The high expression rates of hOGG1 were 50.5% in NPC and and 92.8% in non-tumor nasopharyngeal tissues (P<0.001), and those of ADPRT were 53.5% and 96.4%, respectively (P<0.001). "
|2.||Hepatocellular Carcinoma (Hepatoma)
03/01/2011 - "No associations of polymorphisms in ADPRT with hepatitis B virus clearance and hepatocellular carcinoma occurrence in a Korean population."
03/01/2011 - "We explored whether polymorphisms of ADPRT affect clearance of hepatitis B virus (HBV) infection or risk of hepatocellular carcinoma (HCC) occurrence in a Korean HBV cohort. "
12/01/1989 - "Our previous studies have demonstrated that 3-aminobenzamide (3AB), an inhibitor of adenosine diphosphate-ribosyl transferase (ADPRT) could enhance the cytotoxicity (in vitro) and antitumor activity (in vivo) of bleomycin (BLM) A5 and peplomycin (PEP) against S-180, hepatoma and Ehrlich ascites carcinoma (EAC). "
06/01/2015 - "During the course of infection, increased FOCI size was associated with enhanced disruption of the pulmonary-vascular barrier and increased bacterial dissemination into the blood, both of which were also dependent on the ADPRT activity of ExoS. "
06/01/2015 - "Both of these phenotypes were attenuated in infections caused by bacteria secreting ADPRT-deficient ExoS, indicating that FOCI growth and type I pneumocyte death were dependent on the ADPRT activity of ExoS. "
01/01/2014 - "These results demonstrate for the first time the antiphagocytic function of ExoS in the context of an actual infection and indicate that blocking the ADP-ribosyltransferase activity of ExoS may have potential therapeutic benefit. "
06/01/2011 - "Here we demonstrate that a mutant deficient in the production of the streptococcal ADP-ribosyltransferase SpyA generates lesions of reduced size in a subcutaneous mouse infection model. "
06/01/2011 - "SpyA, a C3-like ADP-ribosyltransferase, contributes to virulence in a mouse subcutaneous model of Streptococcus pyogenes infection."
|4.||Breast Neoplasms (Breast Cancer)
01/01/2012 - "Several studies have evaluated the association between polymorphisms in the two BER genes (ADPRT Val762Ala and APE1 Asp148Glu) and breast cancer risk. "
01/01/2007 - "We have conducted here an exhaustive detailed mutation and haplotype tagging analysis of the ADPRT gene with regard to breast cancer, providing useful data for other large-scale association studies. "
01/01/2007 - "These findings render ADPRT an attractive candidate susceptibility gene for breast cancer, and thus the goal of this study was to evaluate the possible involvement of ADPRT sequence variations in breast cancer susceptibility. "
01/01/2012 - "This meta-analysis indicates that ADPRT Val762Ala and APE1 Asp148Glu polymorphisms are not associated with increased breast cancer risk."
01/01/2012 - "To investigate whether XRCC1 and ADPRT polymorphisms might be associated with outcomes of breast cancer. "
08/01/2006 - "This study examined the effects of ADPRT Val762Ala and XRCC1 Arg399Gln polymorphisms on ADPRT-XRCC1 interaction in vitro in cells and their contributions to gastric cardia adenocarcinoma (GCA) risk. "
10/01/2006 - "pylori had an enzymatic mono-ADP-ribosyltransferase activity which enabled it to modify the 55- and 45-kDa membranous proteins of human gastric adenocarcinoma, as well as the 70-kDa protein of H. "
04/01/1994 - "Since RT6.2 has significant amino acid identity with a GPI-anchored rabbit muscle NAD:arginine ADP-ribosyltransferase, RT6.2 was expressed in rat mammary adenocarcinoma cells and the ability of the expressed protein to catalyze ADP-ribose transfer reactions was examined. "
01/01/1985 - "Galactosyltransferase (GalTF), sialyltransferase (SiaTF), fucosyltransferase (FucTF), 5'-nucleotidase (5'Nucl), and ADP-ribosyltransferase (RibTF) were determined in three subcellular fractions of tumor cells and adjacent control tissue from 20 patients with small primary infiltrating ductal adenocarcinomas of the breast. "
04/04/1997 - "Transfection of NMU (rat mammary adenocarcinoma) cells with NAD:arginine ADP-ribosyltransferase cDNAs from Yac-1 murine lymphoma cells or rabbit muscle increased NAD glycohydrolase and ADP-ribosyltransferase activities. "
|2.||Adenosine Diphosphate (ADP)
|4.||DNA (Deoxyribonucleic Acid)
|5.||Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
|9.||Cytochrome P-450 CYP1A1 (CYP1A1)
|10.||Cytochrome P-450 Enzyme System (Cytochrome P450)
|1.||Drug Therapy (Chemotherapy)
|2.||Induced Hyperthermia (Thermotherapy)